iBio (IBIO) Cash from Operations (2010 - 2026)

iBio (IBIO) has 17 years of Cash from Operations data on file, last reported at 6100000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 96.77% year-over-year to 6100000.0 in Q1 2026; TTM through Mar 2026 was 21600000.0, a 38.87% decrease from a year earlier, with the FY2025 full-year figure at 15300000.0, up 17.54% from the prior year.
• Cash from Operations for Q1 2026 stood at 6100000.0, down from 5235000.0 in the prior quarter.
• Over the last five years, Cash from Operations for IBIO reached as high as 3100000.0 in Q1 2025 and fell as low as 13959000.0 in Q3 2022.
• Historically, Cash from Operations has averaged 5808058.82 across 5 years, with a median of 4970000.0 in 2023.
• Across the five-year window, Cash from Operations jumped 61.75% in 2023 and plunged 96.77% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 7635000.0 in 2022, then jumped by 38.36% to 4706000.0 in 2023, then climbed by 17.45% to 3885000.0 in 2024, then sank by 34.75% to 5235000.0 in 2025, then declined by 16.52% to 6100000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 6100000.0 in Q1 2026, 5235000.0 in Q4 2025, and 5665000.0 in Q3 2025.